je.st
news
Mylan sues Celgene for blocking Revlimid, Thalomid generics
2014-04-04 19:31:32| Biotech - Topix.net
M ylan Inc on Thursday sued Celgene Corp to stop the latter's effort to keep generic versions of two drugs that generate $4.5 billion of annual sales off the market.
Tags: blocking
sues
generics
mylan
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||